Poly Medicure Ltd Stock Price Today (NSE: POLYMED)
Fundamental Score
Poly Medicure Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Poly Medicure Ltd share price today is ₹1191.10, down 5.57% on NSE/BSE as of 30 March 2026. Poly Medicure Ltd (POLYMED) is a Mid-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹19.51K (Cr). The 52-week high for POLYMED share price is ₹2937.60 and the 52-week low is ₹1195.60. At a P/E ratio of 53.89x, POLYMED is currently trading above its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 15.77% and a debt-to-equity ratio of 0.08.
Poly Medicure Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Poly Medicure Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Poly Medicure Share Price
The medical equipment and supplies industry is currently witnessing a surge in demand, driven by an aging global population and increased healthcare spending. In this context, the focus shifts to the financial health of individual players. This analysis examines the current standing of Poly Medicure share price, trading at ₹1389.400024. We will assess its valuation and profitability metrics in relation to its peers.
Poly Medicure Ltd's current Price-to-Earnings (PE) ratio stands at 53.89. This suggests that the market has high expectations for the company's future earnings growth. Comparatively, evaluating sector peers is crucial. While detailed financial information on
Choksi Asia may be limited without access to comprehensive datasets, anecdotal evidence suggests differences in management quality can significantly impact investor confidence and ultimately, the valuation assigned to each company. For example, consistent strategic decision-making regarding international expansion and operational efficiency can impact investor perceptions.A crucial strength of Poly Medicure Ltd is its Return on Capital Employed (ROCE) of 20.08%. This figure indicates how effectively the company is using its capital to generate profits. A high ROCE, like Poly Medicure's, can contribute significantly to the company's "moat" – its competitive advantages that protect it from competitors. A ROCE exceeding the cost of capital suggests that the company is creating value for its shareholders and can sustain its competitive positioning within the medical device market.
This observational financial analysis of Poly Medicure is an excerpt from a broader, 80-parameter fundamental audit that I, Sweta Mishra, have verified. This comprehensive audit also included considerations such as debt levels, cash flow stability, and future growth prospects. Note that this assessment is for informational purposes only and should not be construed as investment advice. Further independent research and professional consultation are advised before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Poly Medicure Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of POLYMED across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (15.77%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (20.08%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (25.83%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (19.44% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (24.88% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (28.38% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.08)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (43.09x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (62.42%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 53.89x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Negative Free Cash Flow (₹-152.93 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Poly Medicure Ltd Financial Statements
Comprehensive financial data for Poly Medicure Ltd including income statement, balance sheet and cash flow
About POLYMED (Poly Medicure Ltd)
Poly Medicure Ltd is a dynamic player in the medical equipment and supplies sector, dedicated to advancing healthcare through innovative and reliable medical devices. The company h...as carved a niche for itself by specializing in the development, production, and distribution of a diverse portfolio of medical products. These products are meticulously engineered to meet the evolving needs of patients and healthcare providers, demonstrating a commitment to improving patient outcomes and streamlining clinical workflows. Poly Medicure is driven by a core philosophy of quality, precision, and customer-centricity, evident in its adherence to stringent manufacturing standards and its dedication to fostering strong relationships with its partners in the medical community. The company's extensive product line reflects its dedication to comprehensive healthcare solutions. Its offerings encompass a wide range of devices crucial for various medical procedures and therapies. These include sophisticated infusion therapy systems designed for precise and controlled medication delivery, as well as vital tools for critical care settings, providing clinicians with the resources they need to manage complex patient conditions effectively. Beyond these core areas, Poly Medicure also supplies essential devices for diagnostics, and specialized equipment for surgical applications, contributing to a holistic approach to patient care. Poly Medicure's commitment extends beyond product development to include a robust global distribution network, ensuring that its medical devices reach healthcare facilities and practitioners around the world. With a strong presence in both domestic and international markets, the company actively collaborates with hospitals, clinics, and other healthcare providers to deliver the latest advancements in medical technology. This global reach, coupled with its dedication to quality and innovation, positions Poly Medicure as a trusted partner in the medical community and a significant contributor to the advancement of healthcare worldwide.
Company Details
Key Leadership
Corporate Events
POLYMED Share Price: Frequently Asked Questions
What is the current share price of Poly Medicure Ltd (POLYMED)?
As of 30 Mar 2026, 12:07 pm IST, Poly Medicure Ltd share price is ₹1191.10. The POLYMED stock has a market capitalisation of ₹19.51K (Cr) on NSE/BSE.
Is POLYMED share price Overvalued or Undervalued?
POLYMED share price is currently trading at a P/E ratio of 53.89x, compared to the industry average of 47.87x. Based on this relative valuation, the Poly Medicure Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of POLYMED share price?
The 52-week high of POLYMED share price is ₹2937.60 and the 52-week low is ₹1195.60. These values are updated daily from NSE/BSE price data.
What factors affect the Poly Medicure Ltd share price?
Key factors influencing POLYMED share price include quarterly earnings growth (Sales Growth: 5.68%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Poly Medicure Ltd a good stock for long-term investment?
Poly Medicure Ltd shows a 5-year Profit Growth of 28.38% and an ROE of 15.77%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.08 before investing in POLYMED shares.
How does Poly Medicure Ltd compare with its industry peers?
Poly Medicure Ltd competes with major peers in the Medical Equipment & Supplies. Investors should compare POLYMED share price P/E of 53.89x and ROE of 15.77% against the industry averages to determine competitive standing.
What is the P/E ratio of POLYMED and what does it mean?
POLYMED share price has a P/E ratio of 53.89x compared to the industry average of 47.87x. Investors pay ₹54 for every ₹1 of annual earnings.
How is POLYMED performing according to Bull Run's analysis?
POLYMED has a Bull Run fundamental score of 60.7/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does POLYMED belong to?
POLYMED operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting Poly Medicure Ltd share price.
What is Return on Equity (ROE) and why is it important for POLYMED?
POLYMED has an ROE of 15.77%, which indicates excellent management efficiency. ROE measures how efficiently Poly Medicure Ltd generates profits from shareholders capital.
How is POLYMED debt-to-equity ratio and what does it indicate?
POLYMED has a debt-to-equity ratio of 0.08, which indicates conservative financing with low financial risk.
What is POLYMED dividend yield and is it a good dividend stock?
POLYMED offers a dividend yield of 0.18%, meaning you receive ₹0.18 annual dividend for every ₹100 invested in Poly Medicure Ltd shares.
How has POLYMED share price grown over the past 5 years?
POLYMED has achieved 5-year growth rates of: Sales Growth 19.44%, Profit Growth 28.38%, and EPS Growth 24.88%.
What is the promoter holding in POLYMED and why does it matter?
Promoters hold 62.42% of POLYMED shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Poly Medicure Ltd.
What is POLYMED market capitalisation category?
POLYMED has a market capitalisation of ₹19506 crores, placing it in the Mid-cap category.
How volatile is POLYMED stock?
POLYMED has a beta of N/A. A beta > 1 suggests the Poly Medicure Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is POLYMED operating profit margin trend?
POLYMED has a 5-year average Operating Profit Margin (OPM) of 25.83%, indicating the company's operational efficiency.
How is POLYMED quarterly performance?
Recent quarterly performance shows Poly Medicure Ltd YoY Sales Growth of 5.68% and YoY Profit Growth of 5.02%.
What is the institutional holding pattern in POLYMED?
POLYMED has FII holding of 9.77% and DII holding of 13.53%. Significant institutional holding often suggests professional confidence in the Poly Medicure Ltd stock.